We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App





Siemens Brings Its Latest Innovations in Laboratory Diagnostics to MEDLAB Middle East 2022

By LabMedica International staff writers
Posted on 26 Jan 2022
Print article
Image: epoc Blood Analyzer (Photo courtesy of Siemens Healthineers)
Image: epoc Blood Analyzer (Photo courtesy of Siemens Healthineers)

Siemens Healthineers (Erlangen, Germany) presented its latest innovations in laboratory diagnostics, including automation solutions for labs of all sizes, virtually as well as live, at the 2022 edition of MEDLAB Middle East.

Siemens demonstrated its Atellica hematology portfolio that pairs automation, intelligence, and extended parameters to streamline operations and support accurate clinical decision-making. The company displayed its two new flagship hematology analyzers - Atellica HEMA 570 and 580 - that are designed to deliver reliable performance targeted for high volume routine workloads. Also on display was the Atellica Solution comprising flexible, scalable, automation-ready immunoassay and chemistry analyzers with integrated automation. Atellica Integrated Automation (AIA) on the Atellica Solution consolidates revolutionary sample management technology, intelligent software, and IT to provide workflow efficiency with the flexibility to add decapping with little or no additional footprint.

In addition, Siemens highlighted its Sysmex CN-3000 and CN-6000 fully automated, mid- and high-volume coagulation analyzers that help meet the small-sized, mid- and high-volume hemostasis testing solutions to tackle big lab challenges. Giants on the inside, combining size, speed, intelligence, and flexibility, the Sysmex CN Systems help transform care delivery through improved workforce productivity.

Siemens demonstrated how Atellica Diagnostics IT provides scalable, easy-to-use solutions to simplify tasks and maximize the effectiveness of the laboratory and its staff. Viewers learnt how Atellica Diagnostics IT can enhance visibility, automate processes, and centralize management across instruments, automation, sites, and networks. Siemens also demonstrated Atellica Inventory Manager, its real-time automated inventory management solution that provides automated, real-time control of reagents and consumables across multiple locations to reduce costs, save time, and improve lab quality. Other lab products highlighted by Siemens at MEDLAB Middle East 2022 included the INNOVANCE VWF Ac assay which sets a new standard in VWF activity determination and its robust menu of inflammatory markers (including a key marker, IL-6) and other lab tests to assess tissue and organ damage that can help clinicians understand the severity of the COVID-19 disease as well as implement timely interventions for patients at risk for cytokine storm.

Related Links:
Siemens Healthineers

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
Gold Member
Veterinary Hematology Analyzer
Exigo H400
New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
New
Rheumatoid Arthritis Test
Finecare RF Rapid Quantitative Test

Print article

Channels

Molecular Diagnostics

view channel
Image: Umbilical cord blood biomarkers may improve preterm infant care (Photo courtesy of Shutterstock)

Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications

Advancements in medical technology and neonatology have significantly improved the care of prematurely born infants. However, these infants still face heightened risks for medical complications, such as... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.